EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase

Alessandra Feoli, Amodio Luca Balzano, Ida Pacilio iD, Alessandra Cipriano, Roman Belle iD, Giacomo Pepe, Manuela Giovanna Basilicata, Pietro Campiglia, Fabrizio Micheli, Akane Kawamura, Ciro Milite iD, Sabrina Castellano iD und 2 weitere

ChemMedChem · 27.05.2026 · 21 (10)

DOI: 10.1002/cmdc.70305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 20.05.2026. Verfasst von Alessandra Feoli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Fisciano, Italy. Hauptthemen laut MEDLINE: Jumonji Domain-Containing Histone Demethylases, Quinazolinones, Enzyme Inhibitors, Quinazolines. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Cancer Research UK funding, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine demethylases of the KDM4 subfamily are epigenetic regulators frequently dysregulated in cancer, yet the identification of cell‐active inhibitors remains challenging due to assay interference and limited chemotype diversity. Here, we report the discovery of 2‐substituted‐3‐hydroxy‐2,3‐dihydroquinazolin‐4(1 H )‐ones as a new class of KDM4A inhibitors. A focused library was identified through a screening cascade integrating biochemical, biophysical, and mass spectrometry–based assays to minimize false positives. Orthogonal validation using surface plasmon resonance, nanodifferential scanning fluorimetry, and MALDI‐TOF‐MS enabled reliable compound prioritization, leading to the identification of compound 6i as a validated KDM4A binder and inhibitor. Cellular target engagement was demonstrated by quantitative label‐free proteomics, revealing a dose‐dependent accumulation of H3K9me2 and H3K9me3 in HEK293T cells, consistent with on‐target inhibition of KDM4‐family demethylases. Compound 6i further exhibited favorable solubility, permeability, and metabolic stability, supporting its qualification as a promising cell‐active KDM4 inhibitor scaffold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Jumonji Domain-Containing Histone DemethylasesQuinazolinonesEnzyme InhibitorsQuinazolinesHumansHEK293 CellsStructure-Activity RelationshipDose-Response Relationship, DrugMolecular Structure

Stichwörter der Autor:innen

2‐oG oxygenasesH3K9 methylationKDM4A inhibitorsepigenetic modulatorshit identificationlysine demethylasemedicinal chemistryorthogonal screeningquinazolinone scaffold

Substanzen

Jumonji Domain-Containing Histone DemethylasesQuinazolinonesEnzyme InhibitorsKDM4A protein, humanQuinazolines

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Fisciano, Italy.
  • Center for Drug Discovery and Development-DMPK, Aptuit, an Evotec Company, Verona, Italy.
  • PhD Program in Drug Discovery and Development, University of Salerno, Fisciano, Italy.
  • School of Natural and Environmental Sciences, Chemistry Bedson Building, Newcastle University, Newcastle upon Tyne, UK.
  • Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Biomedical Center, Protein Analysis Unit, Faculty of Medicine, Ludwig-Maximilians University Munich, Planegg-Martinsried, Germany.

ORCID-Profile: Ida Pacilio, Roman Belle, Ciro Milite, Sabrina Castellano, Axel Imhof, Gianluca Sbardella

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Cancer Research UK funding
  • Deutsche Forschungsgemeinschaft
  • Ministry of Education, University and Research
  • German Research Foundation

Zitieren

APA

Feoli, A., Balzano, A. L., Pacilio, I., Cipriano, A., Belle, R., Pepe, G., Basilicata, M. G., Campiglia, P., Micheli, F., Kawamura, A., Milite, C., Castellano, S., Imhof, A., & Sbardella, G. (2026). Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase. ChemMedChem, 21(10). https://doi.org/10.1002/cmdc.70305

Vancouver

Feoli A, Balzano AL, Pacilio I, Cipriano A, Belle R, Pepe G, et al. Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase. ChemMedChem. 2026;21(10). doi:10.1002/cmdc.70305

BibTeX
@article{Feoli2026,
  author = {Feoli, Alessandra and Balzano, Amodio Luca and Pacilio, Ida and Cipriano, Alessandra and Belle, Roman and Pepe, Giacomo and Basilicata, Manuela Giovanna and Campiglia, Pietro and Micheli, Fabrizio and Kawamura, Akane and Milite, Ciro and Castellano, Sabrina and Imhof, Axel and Sbardella, Gianluca},
  title = {Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {10},
  doi = {10.1002/cmdc.70305}
}
Kostenlos starten →